What is FGFR, and Could It Be a Valuable Target for Patients with Lung Cancer?

Update: 2014-06-11

Description

Dr. Joel Neal of Stanford University Medical Center talks about FGFR - fibroblast growth factor receptor - and how it can impact non-small cell lung cancer growth.

Comments

In Channel

Should Small Cell Lung Cancer Patients Who Respond to Chemo Receive Consolidation Radiotherapy?

2014-07-3104:36

Should All Small Cell Lung Cancer Patients Receive Prophylactic Cranial Irradiation?

2014-07-2705:28

Is Necitumumab An Effective Antibody Against EGFR for Patients with Squamous Lung Cancer?

2014-07-2202:27

Angiogenesis, the Sequel: Does Cyramza (Ramucirumab) Make a Difference for Second Line Treatment?

2014-07-1707:28

Zykadia for ALK Positive Lung Cancer: New Drug, New Hope

2014-07-1307:22

What Went Wrong? The Failure of MetMab with Tarceva in Advanced Non-Small Cell Lung Cancer

2014-07-0803:52

MET-Amplified Lung Cancer: A New Target for XALKORI?

2014-07-0307:18

CO1686 - 3rd Generation Drug for Acquired Resistance in EGFR Lung Cancer

2014-06-2904:10

FGFR and Its Role in Treating Squamous Cell Lung Cancer

2014-06-2502:21

AZD9291 for Acquired Resistance in EGFR Positive Lung Cancer

2014-06-2411:36

What Are Heat Shock Protein (HSP) 90 Inhibitors and How May They Help Fight Lung Cancer?

2014-06-2302:17

The Promise of Immunotherapy in Lung Cancer

2014-06-1801:21

Does Gilotrif Help EGFR Positive Lung Cancer Patients?

2014-06-1808:16

Is Progression-Free Survival Meaningful?

2014-06-1703:25